| GC34397-5mg |
|
— |
Sphistin Synthetic Peptide(12-38,Fitc in N-Terminal-Fluorescently Labeled Peptide)
|
0 |
— |
|
|
|
| GC34397-1mg |
|
— |
Sphistin Synthetic Peptide(12-38,Fitc in N-Terminal-Fluorescently Labeled Peptide)
|
0 |
— |
|
|
|
| GC34396-5mg |
|
— |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat
|
0 |
C162H262N50O52S2 |
|
|
|
| GC34396-1mg |
|
— |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat
|
0 |
C162H262N50O52S2 |
|
|
|
| GC34396-500μg |
|
— |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat
|
0 |
C162H262N50O52S2 |
|
|
|
| GC34395-5mg |
|
— |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA
|
0 |
C162H262N50O52S2.C2HF3O2 |
|
|
|
| GC34395-1mg |
|
— |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA
|
0 |
C162H262N50O52S2.C2HF3O2 |
|
|
|
| GC34395-500μg |
|
— |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA
|
0 |
C162H262N50O52S2.C2HF3O2 |
|
|
|
| GC34394-10mg |
|
— |
β-Melanocyte Stimulating Hormone (MSH), human TFA (Beta-MSH (1-22) (human) (TFA))
|
0 |
C120H175F3N34O37S |
|
|
|
| GC34394-5mg |
|
— |
β-Melanocyte Stimulating Hormone (MSH), human TFA (Beta-MSH (1-22) (human) (TFA))
|
0 |
C120H175F3N34O37S |
|
|
|
| GC34394-1mg |
|
— |
β-Melanocyte Stimulating Hormone (MSH), human TFA (Beta-MSH (1-22) (human) (TFA))
|
0 |
C120H175F3N34O37S |
|
|
|
| GC34393-10mg |
|
— |
|
0 |
C37H62N10O16 |
|
|
|
| GC34393-5mg |
|
— |
|
0 |
C37H62N10O16 |
|
|
|
| GC34393-1mg |
|
— |
|
0 |
C37H62N10O16 |
|
|
|
| GC34392-10mg |
|
— |
|
0 |
C31H54N12O7S2 |
|
|
|
| GC34392-5mg |
|
— |
|
0 |
C31H54N12O7S2 |
|
|
|
| GC34392-1mg |
|
— |
|
0 |
C31H54N12O7S2 |
|
|
|
| GC34391-10mg |
|
— |
β-Amyloid 15-21 (Beta-Amyloid (15-21))
|
0 |
C43H65N9O9 |
|
|
|
| GC34391-5mg |
|
— |
β-Amyloid 15-21 (Beta-Amyloid (15-21))
|
0 |
C43H65N9O9 |
|
|
|
| GC34391-1mg |
|
— |
β-Amyloid 15-21 (Beta-Amyloid (15-21))
|
0 |
C43H65N9O9 |
|
|
|
